GenFleet Therapeutics (Shanghai) Inc. (HKG:2595)
Hong Kong · Delayed Price · Currency is HKD 29.80
+0.10 (0.34%)
Oct 21, 2026, 11:59 AM HKT
HKG:2595 Revenue
GenFleet Therapeutics (Shanghai) had revenue of 42.47M CNY in the half year ending June 30, 2026. This brings the company's total for the last twelve months to 84.00M, down -56.58% year-over-year. In the year 2025, GenFleet Therapeutics (Shanghai) had annual revenue of 130.27M with 24.42% growth. That makes GenFleet Therapeutics (Shanghai) the 36,351st largest company in the world by revenue and 2,211th in Hong Kong.
Revenue (ttm)
84.00M CNY
Revenue Growth
-56.58%
P/S Ratio
113.43
Revenue / Employee
528.28K CNY
Employees
159
Market Cap
11.04B HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 130.27M | 25.56M | 24.42% |
| Dec 31, 2024 | 104.70M | 30.97M | 42.00% |
| Dec 31, 2023 | 73.73M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.